Related Experiment Videos
The infant with primary hyperoxaluria and oxalosis: from diagnosis to multiorgan transplantation
T E Bunchman1, H Majors, G Majors
1University of Michigan Medical Center, Ann Arbor 48109-0297, USA.
Insights
This study details the intensive treatment and successful combined liver and kidney transplant for an infant with primary hyperoxaluria and oxalosis, addressing kidney failure and metabolic defects.
Area of Science:
- Pediatric Nephrology
- Metabolic Disorders
- Transplantation Immunology
Background:
- Primary hyperoxaluria and oxalosis present a severe metabolic challenge in infants, often leading to progressive kidney damage.
- Early diagnosis and intervention are critical for managing this rare genetic condition.
Observation:
- An infant with primary hyperoxaluria and oxalosis experienced an unheralded clinical presentation.
- The infant underwent 9 months of intensive renal replacement therapy, including combined hemodialysis and peritoneal dialysis.
Findings:
- A successful combined liver and kidney transplantation was performed, effectively treating both the kidney failure and the underlying metabolic defect.
- This multidisciplinary approach highlights the potential for definitive management of severe pediatric oxalosis.
Implications:
- Combined liver and kidney transplantation represents the "best therapy" for select infants with primary hyperoxaluria and oxalosis.
- The case underscores the complex ethical considerations and parental involvement in decisions regarding aggressive treatment for rare, life-threatening pediatric diseases.
Abstract:
The care of an infant with primary hyperoxaluria and oxalosis is discussed. After an unheralded presentation, followed by 9 months of intensive treatment that included combined hemodialysis and peritoneal dialysis, the infant successfully underwent combined liver and kidney transplantation to definitely address both kidney failure and the underlying metabolic defect. Discussion of this approach, including ongoing input from the parents, addresses both the implications of undertaking the "best therapy" for this disease as well as the ethical dilemma passed by the decision whether to proceed or not to proceed with therapy.